Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years - Diallo, Aldiouma; Sow, Samba O.; Idoko, Olubukola T.; Hirve, Siddhivinayak; Findlow, Helen; Preziosi, Marie-Pierre; Elie, Cheryl; Kulkarni, Prasad S.; Parulekar, Varsha; Diarra, Bou; Haidara, Fadima Cheick; Diallo, Fatoumata; et al. (Clinical infectious diseases, 2015)
Keywords: Adolescent; Adult; Africa; Animals; Antibodies, Bacterial - blood; Blood Bactericidal Activity; Child; Child, Preschool; Complement System Proteins; Drug dosages; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Healthy Volunteers; Humans; Immunization; Immunoglobulins; India; Male; Meningococcal Vaccines - administration & dosage; Meningococcal Vaccines - immunology; Rabbits; Safety; SEROLOGIC AND SAFETY STUDIES OF A GROUP A MENINGOCOCCAL CONJUGATE VACCINE; The Meningitis Vaccine Project: The Development, Licensure, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa; Time Factors; Vaccines; Young Adult; Africa; India; African meningitis belt; MenA conjugate vaccine; antibody persistence; India